Beta Drugs consolidated net profit rises 0.22% in the March 2026 quarter
(14 May 2026)

Back
Net profit of Beta Drugs rose 0.22% to Rs 9.05 crore in the quarter ended March 2026 as against Rs 9.03 crore during the previous quarter ended March 2025. Sales rose 0.21% to Rs 93.96 crore in the quarter ended March 2026 as against Rs 93.76 crore during the previous quarter ended March 2025.

For the full year,net profit declined 2.22% to Rs 41.48 crore in the year ended March 2026 as against Rs 42.42 crore during the previous year ended March 2025. Sales rose 6.20% to Rs 384.83 crore in the year ended March 2026 as against Rs 362.36 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales93.9693.76 0 384.83362.36 6
OPM %18.8218.50 -19.6720.59 -
PBDT16.6318.02 -8 71.5574.05 -3
PBT11.8314.45 -18 54.3961.54 -12
NP9.059.03 0 41.4842.42 -2

Copyright © 2026 Arihant Capital Markets Ltd. All rights Reserved.

Designed, Developed and Content powered by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)

x
  • QR-CodeNew